TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiation therapy

被引：0
|
作者：
Gao, Chan [1 ]
机构：
[1] City Hope Natl Canc Inst, Duarte, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-C285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C285
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
    Gonzalez-Reyes, Salome
    Fernandez, Jesus M.
    Gonzalez, Luis O.
    Aguirre, Alina
    Suarez, Aurelio
    Gonzalez, Jose M.
    Escaff, Safwan
    Vizoso, Francisco J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (02) : 217 - 226
  • [32] Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
    Salomé González-Reyes
    Jesús M. Fernández
    Luis O. González
    Alina Aguirre
    Aurelio Suárez
    José M. González
    Safwan Escaff
    Francisco J. Vizoso
    Cancer Immunology, Immunotherapy, 2011, 60 : 217 - 226
  • [33] TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression
    Gao, Caixia
    Qiao, Tiankui
    Zhang, Bin
    Yuan, Sujuan
    Zhuang, Xibing
    Luo, Youjun
    ONCOTARGETS AND THERAPY, 2018, 11 : 5963 - 5971
  • [34] CpG Oligodeoxynucleotides as TLR9 AgonistsTherapeutic Applications in Cancer
    Yanal M. Murad
    Timothy M. Clay
    BioDrugs, 2009, 23 : 361 - 375
  • [35] Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy
    Liu, Qi
    Aminu, Bayonle
    Roscow, Olivia
    Zhang, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 26
  • [36] Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors
    Kapp, Kerstin
    Volz, Barbara
    Oswald, Detlef
    Wittig, Burghardt
    Baumann, Matthias
    Schmidt, Manuel
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [37] Comparison of tumor and stroma CD73 expression with TLR9 and survival in breast cancer
    Selander, K.
    Mella, M.
    Kauppila, J.
    Karihtala, P.
    Jukkola-Vuorinen, A.
    Auvinen, P.
    Soini, Y.
    Kauppila, S.
    Haapasaari, K-M
    Harris, K.
    Vuopala, K.
    CANCER RESEARCH, 2016, 76
  • [38] EXPRESSION OF TLR9 AND ITS SIGNALING FUNCTION IN HUMAN HEPATOCELLULAR CARCINOMA
    Tanaka, Junichiro
    Sugimoto, Kazushi
    Tameda, Masahiko
    Nojiri, Keiichiro
    Kusagawa, Satoko
    Beppu, Tetsuya
    Yamamoto, Norihiko
    Shiraki, Katsuya
    Takei, Yoshiyuki
    HEPATOLOGY, 2010, 52 (04) : 599A - 599A
  • [39] Salvage therapy for prostate cancer recurrence after radiation therapy
    Busby J.E.
    Cox J.M.
    Current Urology Reports, 2009, 10 (3) : 199 - 205
  • [40] TLR9 SIGNALING IN FIBROBLASTIC RETICULAR CELLS REGULATES PERITONEAL IMMUNITY
    Li, Yiming
    Xu, Li
    Chen, Tianmeng
    Loughran, Patricia
    Liao, Hong
    Hoffman, Rosemary
    Billiar, Timothy R.
    Deng, Meihong
    SHOCK, 2019, 51 (06): : 53 - 53
12345